$PRTK -- This is on the biopharm post I made earli
Post# of 22755
PRTK
Omadacycline - oral
Acute bacterial skin and skin structure infections (ABSSSI)
Phase 3 Phase 3 completion of enrollment announced May 8, 2017. Data due mid-July 2017. July 15 estimate based on company guidance of "mid-July".
https://twitter.com/twitter/statuses/957208055766241280